Illinois Municipal Retirement Fund Sells 10,030 Shares of Humana Inc. (NYSE:HUM)

Illinois Municipal Retirement Fund cut its holdings in shares of Humana Inc. (NYSE:HUMFree Report) by 29.0% in the 4th quarter, HoldingsChannel reports. The fund owned 24,579 shares of the insurance provider’s stock after selling 10,030 shares during the period. Illinois Municipal Retirement Fund’s holdings in Humana were worth $11,253,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in HUM. Rakuten Securities Inc. purchased a new stake in shares of Humana during the 4th quarter valued at approximately $25,000. Gradient Investments LLC boosted its holdings in Humana by 200.0% in the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after buying an additional 40 shares during the period. Cetera Trust Company N.A bought a new position in Humana in the 4th quarter worth approximately $28,000. Nvwm LLC boosted its holdings in Humana by 41.0% in the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock worth $42,000 after buying an additional 25 shares during the period. Finally, Turtle Creek Wealth Advisors LLC bought a new position in Humana in the 4th quarter worth approximately $55,000. 92.38% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Royal Bank of Canada cut their price target on shares of Humana from $507.00 to $415.00 and set an “outperform” rating for the company in a report on Friday, January 26th. UBS Group reaffirmed a “neutral” rating and set a $370.00 price objective (down from $530.00) on shares of Humana in a report on Friday, January 26th. Bank of America restated a “neutral” rating and issued a $342.00 price objective (down previously from $470.00) on shares of Humana in a research report on Tuesday, April 2nd. Mizuho decreased their price objective on shares of Humana from $550.00 to $400.00 and set a “buy” rating on the stock in a research report on Friday, January 26th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Humana from a “buy” rating to a “hold” rating and decreased their price objective for the company from $595.00 to $360.00 in a research report on Thursday, January 25th. Eleven research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from, the stock has a consensus rating of “Hold” and an average target price of $454.63.

Get Our Latest Stock Analysis on HUM

Insider Buying and Selling at Humana

In other news, Director Jorge S. Mesquita bought 545 shares of the stock in a transaction dated Tuesday, February 20th. The stock was purchased at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the acquisition, the director now owns 2,578 shares of the company’s stock, valued at $946,358.02. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.29% of the stock is owned by company insiders.

Humana Stock Performance

Shares of HUM traded up $1.85 during mid-day trading on Tuesday, hitting $327.15. 562,666 shares of the company traded hands, compared to its average volume of 1,973,769. Humana Inc. has a 1 year low of $299.23 and a 1 year high of $541.21. The stock has a market cap of $39.47 billion, a price-to-earnings ratio of 16.44, a P/E/G ratio of 1.92 and a beta of 0.45. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.59 and a current ratio of 1.59. The stock has a 50-day moving average price of $330.09 and a two-hundred day moving average price of $399.70.

Humana (NYSE:HUMGet Free Report) last announced its quarterly earnings data on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.87). Humana had a return on equity of 19.44% and a net margin of 2.34%. The firm had revenue of $26.46 billion during the quarter, compared to analysts’ expectations of $25.47 billion. During the same period last year, the company earned $1.62 earnings per share. The business’s revenue for the quarter was up 17.9% on a year-over-year basis. Equities analysts anticipate that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 28th. This represents a $3.54 annualized dividend and a yield of 1.08%. Humana’s dividend payout ratio (DPR) is currently 17.86%.

Humana Company Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Further Reading

Want to see what other hedge funds are holding HUM? Visit to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with's FREE daily email newsletter.